Tag: STEM study
Balt’s Squid liquid embolic receives US FDA approval for adjunctive cSDH treatment
Balt has announced the US Food and Drug Administration (FDA) premarket approval (PMA) of its Squid liquid embolic agent, meaning Squid can be used...
SNIS acknowledges “major shift” in chronic SDH treatment following new trial...
In an official statement, the Society of Neurolnterventional Surgery (SNIS) has acknowledged middle meningeal artery (MMA) embolisation as a beneficial adjunctive treatment for chronic...
STEM study finds improved outcomes with MMA embolisation over standard care...
Recently presented results from the STEM randomised controlled trial (RCT) have demonstrated improved outcomes with middle meningeal artery (MMA) embolisation plus standard management—as compared...
